About Ergomed
Ergomed is a company based in Houston (United States) founded in 1997 was acquired by Ergomed in December 2020. It operates as a Professional Services and Managed Services. Ergomed has completed 1 acquisition, including Datatrial. Ergomed offers products and services including Ergomed CARE™, Clinical Development Strategy, and Oncology Trial Solutions. Ergomed operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ergomed Group
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ergomed
Ergomed offers a comprehensive portfolio of products and services, including Ergomed CARE™, Clinical Development Strategy, and Oncology Trial Solutions.
Patient enrollment and engagement are improved through innovative solutions.
Strategic guidance is provided for clinical trial development success.
Specialized solutions are offered for complex oncology clinical trials.
Funding Insights of Ergomed
Detailed funding history for Ergomed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ergomed
Ergomed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical CRO services for oncology and rare diseases are provided.
|
Locked | Locked | Locked |
Investor details for Ergomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ergomed
Ergomed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Datatrial.
Investment portfolio details for Ergomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Datatrial operate in the life science sector offering our proprietary EDC system (nowEDC™), data management, bio-statistical and consulting services
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Ergomed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ergomed
Detailed financials for Ergomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ergomed Comparisons
Peer comparison for Ergomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ergomed
Ergomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
Detailed competitors of Ergomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ergomed
Complete news archive for Ergomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ergomed
Ergomed was founded in 1997.
Ergomed is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Ergomed is established as a global Contract Research Organization (CRO) focused on delivering high-quality clinical research services. Expertise is provided in oncology, rare diseases, and complex trials involving vulnerable populations. Tailored solutions are offered for trial design, regulatory guidance, and patient-centric approaches through proprietary systems like Ergomed CARE. Services span clinical development strategy, site management, and biometrics, ensuring efficient trial execution. Operations are supported across over 100 countries, with a strong U.S. presence in Raleigh and Boston, facilitating responsive clinical development for sponsors worldwide.
Ergomed's top competitors include Emmes, Syneos Health and ClinChoice.
Ergomed offers Ergomed CARE™, Clinical Development Strategy, and Oncology Trial Solutions.
Ergomed has made 1 acquisition, including Datatrial.
Ergomed has 1 investor. Key investors include Ergomed.